BRAF and adenocarcinoma: Additionally, we found that sample 6935 had co-occurring mutations in PI3K (PIK3CA) and RTK-RAS (BRAF) pathways, and the patient suffered a poorly differentiated adenocarcinoma in the ascending colon.